Short term results of intra-vitreal bevacizumab for the treatment of macular edema secondary to retinal vein occlusion. [electronic resource]
Producer: 20140211Description: 63-8 p. digitalISSN:- 2072-6805
- Adult
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Bevacizumab
- Dose-Response Relationship, Drug
- Female
- Fluorescein Angiography
- Follow-Up Studies
- Fundus Oculi
- Humans
- Intravitreal Injections
- Macular Edema -- diagnosis
- Male
- Middle Aged
- Prospective Studies
- Retinal Vein Occlusion -- complications
- Time Factors
- Tomography, Optical Coherence
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
- Young Adult
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.